ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,738, issued on June 10, was assigned to CSL BEHRING AG (Bern, Switzerland).
"Treatment of CIDP" was invented by Vera Bril (Toronto) and John-Philip Lawo (Schwanewede, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an immunoglobulin therapy. In particular, an immunoglobulin therapy for treating CIDP with non-axonal damage or mild axonal damage is provided."
The patent was filed on May 23, 2019, under Application No. 17/056,632.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.ht...